Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Specific antitumor cytotoxicity of peripheral blood platelets of lung cancer patients

  • 18 Accesses

  • 3 Citations

This is a preview of subscription content, log in to check access.

Literature Cited

  1. 1.

    S. N. Bykovskaya, M. S. Iobadze, T. A. Kupriyanova, et al., Byull. Éksp. Biol. Med., No. 1, 86 (1987).

  2. 2.

    D. B. Amos, Ann. N. Y. Acad. Sci.,87, 273 (1960).

  3. 3.

    J.-C. Cerottini and K. T. Brunner, Adv. Immunol.,18, 67, (1974).

  4. 4.

    M. I. Grethen, N. E. Kay, R. J. Johnson, et al., Blood,65, 1252 (1985).

  5. 5.

    R. B. Herberman, J. Y. Djeu, and H. D. Kay, Immunol. Rev.,44, 43 (1979).

  6. 6.

    I. R. Pasternac, R. J. Johnson, and H. S. Shin, J. Immunol.,120, 1560 (1978).

  7. 7.

    P. Skov Madsen, P. Hokland, and M. Hokland, Acta Path. Microbiol. Scand., Sec C,94, 193 (1984).

  8. 8.

    A. Uchida and M. Moore, Cancer Immunol. Immunother.,20, 29 (1985).

Download references

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Bykovskaya, S.N., Blokhina, N.G., Speranskii, D.L. et al. Specific antitumor cytotoxicity of peripheral blood platelets of lung cancer patients. Bull Exp Biol Med 105, 842–844 (1988). https://doi.org/10.1007/BF00842144

Download citation

Key Words

  • platelet
  • cytotoxicity
  • lung cancer